“Off-The-Shelf” Third Party T Cells for CAR-T Therapy Under Investigation – Cancer Network
The Advertiser |
“Off-The-Shelf” Third Party T Cells for CAR-T Therapy Under Investigation
Cancer Network A matched donor with similar immunity is not required and neither are the patient's own T cells. “We were able to efficiently (> 90%) delete both copies of CD7 and the T-cell receptor alpha subunit (TRAC) and insert a unique CAR to CD7 in human T cells … Adelaide's Carina Biotech makes killer cells to cure cancer |
